{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20260406",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "63459",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/211533Orig1s000TAltr.pdf",
              "date": "20200609",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA211533",
      "sponsor_name": "MSN",
      "openfda": {
        "application_number": [
          "ANDA211533"
        ],
        "brand_name": [
          "DAPAGLIFLOZIN AND SAXAGLIPTIN"
        ],
        "generic_name": [
          "DAPAGLIFLOZIN AND SAXAGLIPTIN"
        ],
        "manufacturer_name": [
          "Novadoz Pharmaceuticals LLC"
        ],
        "product_ndc": [
          "72205-438"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DAPAGLIFLOZIN",
          "SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE"
        ],
        "rxcui": [
          "1925498"
        ],
        "spl_id": [
          "1cfa51fd-8406-404c-b2a8-0fc1068675fb"
        ],
        "spl_set_id": [
          "1cfa51fd-8406-404c-b2a8-0fc1068675fb"
        ],
        "package_ndc": [
          "72205-438-01",
          "72205-438-02"
        ],
        "nui": [
          "N0000187059",
          "N0000187058"
        ],
        "pharm_class_epc": [
          "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
        ],
        "unii": [
          "1ULL0QJ8UC",
          "4N19ON48ZN"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "DAPAGLIFLOZIN",
              "strength": "10MG"
            },
            {
              "name": "SAXAGLIPTIN HYDROCHLORIDE",
              "strength": "EQ 5MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}